Simplex Trading, LLC Regencell Bioscience Holdings LTD Transaction History
Simplex Trading, LLC
- $195 Billion
- Q3 2025
A detailed history of Simplex Trading, LLC transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Simplex Trading, LLC holds 217 shares of RGC stock, worth $2,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217Holding current value
$2,734% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGC
# of Institutions
21Shares Held
625KCall Options Held
73.8KPut Options Held
105K-
Geode Capital Management, LLC Boston, MA420KShares$5.29 Million0.0% of portfolio
-
Squarepoint Ops LLC New York, NY51.2KShares$645,7370.0% of portfolio
-
Discovery Capital Management, LLC South Norwalk, CT46.2KShares$581,6910.06% of portfolio
-
Xtx Topco LTD London, X038.7KShares$488,0610.03% of portfolio
-
Morgan Stanley New York, NY37.8KShares$476,8090.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $164M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...